Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
$1.91
-6.4%
$4.02
$1.05
$12.50
$13.43M-0.99178,530 shs345,200 shs
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$0.25
+10.3%
$0.24
$0.12
$2.93
$10.70M0.072.61 million shs3.98 million shs
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$2.83
-3.1%
$0.00
$2.20
$38.10
$2.93M0.515.53 million shs13,907 shs
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$2.86
-4.0%
$3.61
$2.75
$13.52
$13.83M0.25381,842 shs109,164 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
-6.37%-6.37%-51.40%-64.70%+190,999,900.00%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
+10.31%-7.15%+0.65%+25.91%-91.61%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-3.08%-27.06%+16.94%+282,999,900.00%+282,999,900.00%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-4.03%-10.63%-19.57%-29.66%-75.34%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.8364 of 5 stars
0.05.00.00.01.01.70.0
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.8467 of 5 stars
3.72.00.03.51.40.81.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
0.00
N/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
0.00
N/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
0.00
N/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
3.40
Buy$23.67727.51% Upside

Current Analyst Ratings Breakdown

Latest XAGE, XAIR, BDMD, and DHAI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
D Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/17/2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$11.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
$64.47M0.18N/AN/A($0.80) per share-0.31
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
$50K56.60N/AN/A($6.77) per share-0.42
Beyond Air, Inc. stock logo
XAIR
Beyond Air
$3.70M3.59N/AN/A$3.32 per share0.86
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/A0.00N/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
-$8.44M-$0.30N/AN/A-13.59%N/A-25.97%N/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
-$10.37MN/A0.00N/A-1,535.11%N/A-280.07%N/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$46.62M-$15.80N/AN/AN/A-1,258.46%-233.96%-113.92%8/12/2025 (Estimated)

Latest XAGE, XAIR, BDMD, and DHAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q1 2026
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$0.08N/AN/AN/A$1.75 millionN/A
6/17/2025Q4 2025
Beyond Air, Inc. stock logo
XAIR
Beyond Air
-$2.80-$1.80+$1.00-$0.09$1.39 million$1.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/AN/AN/AN/AN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/AN/AN/AN/AN/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/AN/AN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A
0.51
0.34
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
N/A
0.42
0.21
Beyond Air, Inc. stock logo
XAIR
Beyond Air
0.64
3.20
2.72

Institutional Ownership

CompanyInstitutional Ownership
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
19.78%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
27.76%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
24.22%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
31.50%

Insider Ownership

CompanyInsider Ownership
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
78.90%
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
49.58%
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
29.00%
Beyond Air, Inc. stock logo
XAIR
Beyond Air
19.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baird Medical Investment Holdings Limited stock logo
BDMD
Baird Medical Investment
N/A6.58 million1.39 millionN/A
DIH Holding US, Inc. stock logo
DHAI
DIH Holding US
N/A47.34 million23.87 millionN/A
Longevity Health Holdings, Inc. stock logo
XAGE
Longevity Health
141.00 million713,000N/A
Beyond Air, Inc. stock logo
XAIR
Beyond Air
704.64 million3.74 millionOptionable

Recent News About These Companies

Beyond Air (NASDAQ:XAIR) Raised to Hold at Wall Street Zen
Beyond Air, Inc. (XAIR) - Yahoo Finance
Beyond Air Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Baird Medical Investment stock logo

Baird Medical Investment NASDAQ:BDMD

$1.91 -0.13 (-6.37%)
As of 08/1/2025 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

DIH Holding US stock logo

DIH Holding US NASDAQ:DHAI

$0.25 +0.02 (+10.31%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$0.24 -0.01 (-4.13%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.

Longevity Health stock logo

Longevity Health NASDAQ:XAGE

$2.83 -0.09 (-3.08%)
As of 08/1/2025 04:00 PM Eastern

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Beyond Air stock logo

Beyond Air NASDAQ:XAIR

$2.86 -0.12 (-4.03%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.96 +0.10 (+3.50%)
As of 08/1/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.